Kamada (KMDA) Accounts Payables (2012 - 2026)
Kamada's (KMDA) quarterly Accounts Payables came in at $21.9 million in Q1 2026, down 11.73% YoY from $24.9 million in Q1 2025, and down 5.61% on a QoQ basis from $23.2 million in Q4 2025.
Kamada (KMDA) Accounts Payables (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Accounts Payables data on file, last reported at $21.9 million in Q1 2026.
- Quarterly Accounts Payables fell 11.73% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 11.73% YoY) and the FY2025 annual result came in at $23.2 million, down 16.2% from the prior year.
- Accounts Payables eased to $21.9 million in Q1 2026, from $23.2 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $32.9 million in Q4 2022 to a low of $26210.0 in Q1 2023.
- A 5-year average of $19.2 million and a median of $21.9 million in 2026 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2022 — Accounts Payables plunged 99.84% — and 2024, when it jumped 62822.55%.
- Tracing KMDA's Accounts Payables over 5 years: stood at $32.9 million in 2022, then declined by 24.65% to $24.8 million in 2023, then advanced by 11.82% to $27.7 million in 2024, then fell by 16.2% to $23.2 million in 2025, then declined by 5.61% to $21.9 million in 2026.
- The last three Accounts Payables figures came in at $21.9 million (Q1 2026), $23.2 million (Q4 2025), and $24.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | -5.09 Bn |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 452.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 356.00 Mn |
| 10 | Kamada | 461.75 Mn | 432.27 Mn | 22.47 Mn | 28.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 28.35 Mn |
| Mar 31, 2026 | 21.94 Mn |
| Dec 31, 2025 | 23.24 Mn |
| Sep 30, 2025 | 24.88 Mn |
| Jun 30, 2025 | 25.08 Mn |
| Mar 31, 2025 | 24.85 Mn |
| Dec 31, 2024 | 27.74 Mn |
| Sep 30, 2024 | 14.79 Mn |
| Jun 30, 2024 | 19.53 Mn |
| Mar 31, 2024 | 16.49 Mn |
| Dec 31, 2023 | 24.80 Mn |
| Sep 30, 2023 | 12.81 Mn |
| Jun 30, 2023 | 27.97 Mn |
| Mar 31, 2023 | 26,210.00 |
| Dec 31, 2022 | 32.92 Mn |
| Sep 30, 2022 | 30,619.00 |
| Jun 30, 2022 | 17.95 Mn |
| Mar 31, 2022 | 11.68 Mn |
| Dec 31, 2021 | 25.10 Mn |
| Sep 30, 2021 | 19.01 Mn |